R.D. Callander
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 26
- Chemical Health and Safety top 5%
-
- Effects and risks of endocrine disrupting chemicals 5
- Indoor Air Quality and Microbial Exposure 4
- Small Animals top 5%
-
- Pharmacogenetics and Drug Metabolism 4
-
- DNA Repair Mechanisms 6
- Cancer therapeutics and mechanisms 4
- Genomics, phytochemicals, and oxidative stress 3
-
- Pesticide Exposure and Toxicity 6
R.D. Callander
36 papers receiving 577 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 380
- Chemical Health and Safety 13
- Health, Toxicology and Mutagenesis 169
- Small Animals 60
- Pharmacology 37
Countries citing papers authored by R.D. Callander
This map shows the geographic impact of R.D. Callander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.D. Callander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.D. Callander more than expected).
Fields of papers citing papers by R.D. Callander
This network shows the impact of papers produced by R.D. Callander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.D. Callander. The network helps show where R.D. Callander may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R.D. Callander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 14 | |
| 2 | 2013 | 26 | |
| 3 | 1997 | 27 | |
| 4 | 1995 | 33 | |
| 5 | 1994 | 35 | |
| 6 | 1994 | 44 | |
| 7 | 1993 | 14 | |
| 8 | 1993 | 39 | |
| 9 | 1993 | 25 | |
| 10 | 1992 | 14 | |
| 11 | 1990 | 29 | |
| 12 | 1990 | 11 | |
| 13 | 1990 | 9 | |
| 14 | 1990 | 18 | |
| 15 | 1988 | 10 | |
| 16 | 1988 | 33 | |
| 17 | 1987 | 1 | |
| 18 | 1986 | 8 | |
| 19 | 1984 | 5 | |
| 20 | 1980 | 3 |
About R.D. Callander
R.D. Callander is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis, Pharmacology, Small Animals and Molecular Medicine, having authored 36 papers that have together received 630 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (26 papers), DNA Repair Mechanisms (6 papers), Pesticide Exposure and Toxicity (6 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Indoor Air Quality and Microbial Exposure (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Cancer therapeutics and mechanisms (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). The work is most often cited by research in Cancer Research (380 citations), Chemical Health and Safety (13 citations), Health, Toxicology and Mutagenesis (169 citations), Small Animals (60 citations) and Pharmacology (37 citations). R.D. Callander has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include J. Ashby, H. Tinwell, John Ashby, Patrick Lefèvre, Ian Kimber, T. Green, Robert J. Graves, D. Patón, Ruth Roberts and J.A. Styles. Their work appears in journals such as Mutagenesis, Regulatory Toxicology and Pharmacology, Mutation research. Fundamental and molecular mechanisms of mutagenesis, Carcinogenesis and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.